Intrinsic Value of S&P & Nasdaq Contact Us

Sera Prognostics, Inc. SERA NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+133.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Sera Prognostics, Inc. (SERA) has a negative trailing P/E of -3.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -28.02%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+133.6%).
  • Trailing Earnings Yield -28.02% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $5.00 (+133.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SERA

Valuation Multiples
P/E (TTM)-3.6
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.51
P/S Ratio1,074.59
EV/EBITDA-2.4
Per Share Data
EPS (TTM)$-0.64
Book Value / Share$1.51
Revenue / Share$0.00
FCF / Share$-0.53
Yields & Fair Value
Earnings Yield-28.02%
Dividend Yield0.00%
Analyst Target$5.00 (+133.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -13.0 0.00 19.67 5,985.53 -
2020 -10.9 -2.04 73.29 8,619.16 -
2021 -6.0 7.19 1.53 2,578.27 -
2022 -0.9 -0.04 0.39 145.48 -
2023 -5.1 0.27 2.66 609.74 -
2024 -8.2 0.56 5.65 3,505.16 -
2025 -4.4 0.14 1.86 1,735.84 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.67 $36K $-20.44M -56775%
2020 $-0.70 $25K $-21.61M -86428%
2021 $-1.18 $82K $-36.23M -44180.5%
2022 $-1.43 $268K $-44.25M -16510.1%
2023 $-1.16 $306K $-36.24M -11843.8%
2024 $-0.99 $77K $-32.9M -42724.7%
2025 $-0.67 $81K $-31.93M -39417.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.67 $-1.05 – $-0.25 $333.33K $266.67K – $400K 1
2027 $-0.67 $-1.05 – $-0.25 $2.17M $1.69M – $2.64M 1
2028 $-0.37 $-0.58 – $-0.14 $5.19M $2.65M – $7.42M 1
2029 $-0.62 $-0.97 – $-0.23 $19.3M $9.86M – $27.6M 1
2030 $-0.44 $-0.69 – $-0.16 $35.7M $18.23M – $51.06M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message